original ) (raw )Idiopathic membranous nephropathy and anti-phospholipase A2 receptor antibodies
Arif Asif , Ali Nayer
Journal of nephropathology, 2013
View PDFchevron_right
Anti-phospholipase A2 receptor antibodies in the diagnosis of idiopathic membranous nephropathy
H. Viana
View PDFchevron_right
Phospholipase A2 receptor (PLA2R) related membranous nephropathy - not specific for idiopathic cases any more
Bahar Bastani
Journal of Nephropathology
View PDFchevron_right
Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy
Mohd Fauzi
PLOS ONE, 2019
View PDFchevron_right
The serum level of anti-phospholipase A2 receptor antibody does not predict severity of proteinuria in primary membranous glomerulonephritis
nazanin samandari
Journal of Renal Injury Prevention, 2020
View PDFchevron_right
Detection of Phospholipase A2 Receptor Related Membranous Nephropathy in Membranous Nephropathy Patient
Alaa Elmaghraby
SVU-International Journal of Medical Sciences, 2020
View PDFchevron_right
Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1
Lars Komorowski , Wolfgang Schlumberger
2014
View PDFchevron_right
An Evaluation of the Level of Anti-phospholipase A2 Receptor (PLA2R) Antibody in Different Pathological Types of Glomerulonephritis
mubabol journal
Journal of Babol University of Medical Sciences, 2017
View PDFchevron_right
Anti-Phospholipase A2 Receptor Antibodies in Recurrent Membranous Nephropathy
Sanjeev Sethi
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015
View PDFchevron_right
Faculty of 1000 evaluation for M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy
David Goldsmith
F1000 - Post-publication peer review of the biomedical literature, 2009
View PDFchevron_right
Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods
Mark Haas
Clinical Nephrology, 2015
View PDFchevron_right
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases
Francesca Pregnolato
Journal of Nephrology, 2017
View PDFchevron_right
A rare case of concurrent myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated necrotising and crescentic glomerulonephritis and membranous glomerulonephritis
Richard Phoon
Pathology, 2017
View PDFchevron_right
Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
Marilina Tampoia
Journal of Nephrology, 2020
View PDFchevron_right
Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy – a retrospective cohort study
Dimitra Kalavrizioti
Romanian Journal of Internal Medicine
View PDFchevron_right
Autoantibodies Specific for the Phospholipase A2 Receptor in Recurrent and De Novo Membranous Nephropathy
C. Mousson
American Journal of Transplantation, 2011
View PDFchevron_right
Anti-phospholipase A2 receptor antibody in membranous nephropathy; an Indian experience
sonia mehrotra
Journal of Renal Injury Prevention
View PDFchevron_right
Autoantibodies against phospholipase A2 receptor in Brazilian patients with glomerular diseases
Gianna Mastroianni Kirsztajn
International Urology and Nephrology, 2020
View PDFchevron_right
Membranous nephropathy
Marcio Dantas
Brazilian Journal of Nephrology
View PDFchevron_right
Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study
jan willem cohen tervaert
American journal of clinical pathology, 2014
View PDFchevron_right
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy
Andreea Andronesi
BioMed Research International, 2015
View PDFchevron_right
The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation
Jesús Villarreal
Clinical kidney journal, 2018
View PDFchevron_right
Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies
Erick Messias
Modern Pathology, 2012
View PDFchevron_right
Anti–Phospholipase A2 Receptor Antibodies and Malignancy in Membranous Nephropathy
P. van Paassen , jan willem cohen tervaert
American Journal of Kidney Diseases, 2013
View PDFchevron_right
Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy
P. Ronco
Journal of the American Society of Nephrology, 2012
View PDFchevron_right
Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings
Saime Paydas
International Journal of Clinical Practice, 2020
View PDFchevron_right
Pathophysiological advances in membranous nephropathy: time for a shift in patient's care
Hanna Debiec
The Lancet, 2015
View PDFchevron_right
Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy
Pietro Ravani
Clinical Journal of the American Society of Nephrology, 2012
View PDFchevron_right
Antiphospholipase A 2 Receptor Autoantibodies: A Comparison of Three Different Immunoassays for the Diagnosis of Idiopathic Membranous Nephropathy
Marvin Fritzler
Journal of Immunology Research, 2014
View PDFchevron_right
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy
Hanna Debiec
Nephrology Dialysis Transplantation, 2012
View PDFchevron_right